Precision oncology in surgery: patient selection for operable pancreatic cancer

- Dreyer, Stephan B., Pinese, Mark, Jamieson, Nigel B., Scarlett, Christopher J., Colvin, Emily K., Pajic, Marina, Johns, Amber L., Humphris, Jeremy L., Wu, Jianmin, Cowley, Mark J., Chou, Angela, Nagrial, Adnan M., Chantrill, Lorraine, Chin, Venessa T., Jones, Marc D., Moran-Jones, Kim, Carter, Christopher Ross, Dickson, Euan J., Samra, Jaswinder S., Merrett, Neil D., Gill, Anthony J., Kench, JG, Duthie, F, Miller, DK, Cooke, S, Aust, D, Knösel, T, Rümmele, P, Grützmann, R, Pilarsky, C, Nguyen, NQ, Musgrove, EA, Bailey, PJ, McKay, CJ, Biankin, AV, Chang, DK, Australian Pancreatic Cancer Genome Initiative, Glasgow Precision Oncology Laboratory

Hypermutation in pancreatic cancer

- Humphris, Jeremy L., Patch, Ann-Marie, Quinn, Michael C. J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Stone, Andrew, Wilson, Peter J., Nones, Katia, Scarlett, Christopher J., Bailey, Peter J., Johns, Amber L., McKay, Skye, Chang, David K., Miller, David K., Pajic, Marina, Kassahn, Karin S.

The epigenetic agents suberoylanilide hydroxamic acid and 5-AZA-2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo

- Susanto, Johana M., Colvin, Emily K., Biankin, Andrew V., Scarlett, Christopher J., Pinese, Mark, Chang, David K., Pajic, Marina, Mawson, Amanda, Caldon, C. Elizabeth, Musgrove, Elizabeth A., Henshall, Susan M., Sutherland, Robert L.

Whole genomes redefine the mutational landscape of pancreatic cancer

- Waddell, Nicola, Pajic, Marina, Quinn, Michael C. J., Robertson, Alan J., Fadlullah, Muhammad Z. H., Bruxner, Tim J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Patch, Ann-Marie, Scarlett, Christopher J., Chang, David K., Kassahn, Karin S., Bailey, Peter, Johns, Amber L., Miller, David, Nones, Katia, Quek, Kelly

Clinical and pathologic features of familial pancreatic cancer

- Humphris, Jeremy L., Johns, Amber L., Mead, R. Scott, Gill, Anthony J., Samra, Jaswinder S., Kench, James G., Musgrove, Elizabeth A., Tucker, Katherine M., Spigelman, Allan D., Waddell, Nic, Grimmond, Sean M., Biankin, Andrew V. Biankin, Simpson, Skye H., Australian Pancreatic Cancer Genome Initiative,, Cowley, Mark J., Pajic, Marina, Chang, David K., Nagrial, Adnan M., Chin, Venessa T., Chantrill, Lorraine A., Pinese, Mark

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater

- Chang, David K., Jamieson, Nigel B., Nagrial, Adnan M., Chantrill, Lorraine A., Chin, Venessa T., Pinho, Andreia V., Rooman, Ilse, Cowley, Mark J., Wu, Jianmin, Mead, R. Scott, Colvin, Emily K., Samra, Jaswinder S., Johns, Amber L., Corbo, Vincenzo, Bassi, Claudio, Falconi, Massimo, Lawlor, Rita T., Crippa, Stefano, Sperandio, Nicola, Bersani, Samantha, Dickson, Euan J., Mohamed, Mohamed A. A., Oien, Karin A., Scarlett, Christopher J., Foulis, Alan K., Musgrove, Elizabeth A., Sutherland, Robert L., Kench, James G., Carter, C. Ross, Gill, Anthony J., Scarpa, Aldo, McKay, Colin J., Biankin, Andrew V., Pajic, Marina, Chou, Angela, Pinese, Mark, Humphris, Jeremy L., Jones, Marc D., Toon, Christopher